EP3646874C0 - Zubereitung zur transdermalen absorption von phosphatidylcholin - Google Patents

Zubereitung zur transdermalen absorption von phosphatidylcholin

Info

Publication number: EP3646874C0
Authority: EP; European Patent Office
Prior art keywords: phosphatidylcholine; preparation; transdermal absorption; transdermal; absorption
Prior art date: 2018-01-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

EP18904440.7A

Other languages

English (en)

French (fr)

Other versions

EP3646874A1 (de

EP3646874B1 (de

EP3646874A4 (de

Inventor

Hirofumi Nakanishi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Unish Inc

Original Assignee

Unish Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-01-31

Filing date

2018-04-27

Publication date

2024-01-24

2018-04-27 Application filed by Unish Inc filed Critical Unish Inc

2020-05-06 Publication of EP3646874A1 publication Critical patent/EP3646874A1/de

2021-03-17 Publication of EP3646874A4 publication Critical patent/EP3646874A4/de

2024-01-24 Application granted granted Critical

2024-01-24 Publication of EP3646874C0 publication Critical patent/EP3646874C0/de

2024-01-24 Publication of EP3646874B1 publication Critical patent/EP3646874B1/de

Status Active legal-status Critical Current

2038-04-27 Anticipated expiration legal-status Critical

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Child & Adolescent Psychology (AREA)
Hematology (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP18904440.7A 2018-01-31 2018-04-27 Zubereitung zur transdermalen absorption von phosphatidylcholin Active EP3646874B1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2018015574		2018-01-31
PCT/JP2018/017312 WO2019150594A1 (ja)	2018-01-31	2018-04-27	ホスファチジルコリン経皮吸収製剤

Publications (4)

Publication Number	Publication Date
EP3646874A1 EP3646874A1 (de)	2020-05-06
EP3646874A4 EP3646874A4 (de)	2021-03-17
EP3646874C0 true EP3646874C0 (de)	2024-01-24
EP3646874B1 EP3646874B1 (de)	2024-01-24

Family

ID=67479703

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP18904440.7A Active EP3646874B1 (de)	2018-01-31	2018-04-27	Zubereitung zur transdermalen absorption von phosphatidylcholin

Country Status (5)

Country	Link
US (1)	US11202763B2 (de)
EP (1)	EP3646874B1 (de)
JP (1)	JP6940889B2 (de)
CN (1)	CN110678185A (de)
WO (1)	WO2019150594A1 (de)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5553649A (en)	1978-10-13	1980-04-19	Hitachi Ltd	Humidifier
JPS6057491B2 (ja)	1980-09-05	1985-12-16	川崎製鉄株式会社	連続焼鈍炉におけるハ−スロ−ル
JPS5955819A (ja) *	1982-09-24	1984-03-31	Nitto Electric Ind Co Ltd	粘着性貼付製剤用膏体
JP3313891B2 (ja) *	1994-06-21	2002-08-12	ポーラ化成工業株式会社	経皮吸収促進剤及び皮膚外用剤
US20040018237A1 (en) *	2002-05-31	2004-01-29	Perricone Nicholas V.	Topical drug delivery using phosphatidylcholine
DE10349979B4 (de)	2003-10-24	2006-05-18	Sanofi-Aventis Deutschland Gmbh	Medikamentöse gezielte lokale Lipolyse
US20090028806A1 (en) *	2005-02-25	2009-01-29	Shigeo Suzuki	Medicine for External Application Containing Anti-Inflammatory Agent and Soy Lecithin
DE102007015090A1 (de) *	2007-03-29	2008-10-02	Robert Bosch Gmbh	Blisteranordnung sowie Kartonzuschnitt hierfür
WO2008133272A1 (ja) *	2007-04-23	2008-11-06	Hisamitsu Pharmaceutical Co., Inc.	貼付剤
ITVR20070150A1 (it)	2007-10-23	2009-04-24	Phytonature Sas	Prodotto cosmetico per la lipolisi non invasiva del grasso sottocutaneo ed il trattamento della cellulite
CN102481305B (zh) *	2009-08-25	2015-08-19	美德阿利克斯株式会社	磷脂酰胆碱的经皮组合物及其制备方法
WO2013027681A1 (ja)	2011-08-19	2013-02-28	株式会社ケイ・エムトランスダーム	貼付剤
ES2660978T3 (es)	2012-10-11	2018-03-26	Anaplasi Pharmaceuticals Llc	Método y composiciones para el tratamiento de la psoriasis
KR20140143938A (ko)	2013-06-10	2014-12-18	(주)휴레브	저주파 치료용 패치
US11660344B2 (en)	2013-11-17	2023-05-30	Medrx Co., Ltd.	Transdermal colloidal solution agent
CA2872279C (en)	2014-11-21	2018-06-12	Pankaj Modi	Topical lipolysis compositions and methods
JP6623084B2 (ja)	2016-02-29	2019-12-18	株式会社カネカ	Ｓ／ｏ型貼付剤

2018
- 2018-04-27 EP EP18904440.7A patent/EP3646874B1/de active Active
- 2018-04-27 CN CN201880035390.2A patent/CN110678185A/zh active Pending
- 2018-04-27 US US16/618,026 patent/US11202763B2/en active Active
- 2018-04-27 JP JP2019508997A patent/JP6940889B2/ja active Active
- 2018-04-27 WO PCT/JP2018/017312 patent/WO2019150594A1/ja not_active Ceased

Also Published As

Publication number	Publication date
CN110678185A (zh)	2020-01-10
JPWO2019150594A1 (ja)	2020-08-20
EP3646874A1 (de)	2020-05-06
WO2019150594A1 (ja)	2019-08-08
JP6940889B2 (ja)	2021-09-29
US20200138731A1 (en)	2020-05-07
EP3646874B1 (de)	2024-01-24
EP3646874A4 (de)	2021-03-17
US11202763B2 (en)	2021-12-21

Legal Events

Date	Code	Title	Description
2019-08-10	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2020-04-03	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2020-04-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2020-05-06	17P	Request for examination filed	Effective date: 20191204
2020-05-06	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2020-05-06	AX	Request for extension of the european patent	Extension state: BA ME
2021-03-17	A4	Supplementary search report drawn up and despatched	Effective date: 20210216
2021-03-17	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 47/18 20170101ALI20210210BHEP Ipc: A61P 3/06 20060101ALI20210210BHEP Ipc: A61K 9/70 20060101ALI20210210BHEP Ipc: A61K 47/44 20170101ALI20210210BHEP Ipc: A61K 31/685 20060101AFI20210210BHEP Ipc: A61K 47/32 20060101ALI20210210BHEP
2021-05-05	DAV	Request for validation of the european patent (deleted)
2021-05-05	DAX	Request for extension of the european patent (deleted)
2022-01-14	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2022-02-16	17Q	First examination report despatched	Effective date: 20220118
2022-08-24	REG	Reference to a national code	Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0031685000 Ipc: A61P0003040000 Ref country code: DE Ref legal event code: R079 Ref document number: 602018064676 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61K0031685000 Ipc: A61P0003040000
2022-09-25	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2022-09-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2022-09-28	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/70 20060101ALI20220824BHEP Ipc: A61K 31/685 20060101ALI20220824BHEP Ipc: A61P 3/04 20060101AFI20220824BHEP
2022-10-26	INTG	Intention to grant announced	Effective date: 20220926
2022-12-06	GRAJ	Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted	Free format text: ORIGINAL CODE: EPIDOSDIGR1
2022-12-06	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2023-01-11	INTC	Intention to grant announced (deleted)
2023-09-19	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2023-09-19	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2023-10-18	INTG	Intention to grant announced	Effective date: 20230920
2023-12-15	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2023-12-22	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2023-12-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE PATENT HAS BEEN GRANTED
2024-01-24	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2024-01-24	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2024-01-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2024-02-14	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2024-02-15	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602018064676 Country of ref document: DE
2024-03-13	U01	Request for unitary effect filed	Effective date: 20240207
2024-03-20	U07	Unitary effect registered	Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI Effective date: 20240215
2024-05-29	U20	Renewal fee for the european patent with unitary effect paid	Year of fee payment: 7 Effective date: 20240424
2024-07-01	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240524
2024-07-15	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240425
2024-07-18	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240424
2024-07-22	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240424 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240424 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240524 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240425 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-08-01	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-08-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-10-14	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-10-23	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-10-25	REG	Reference to a national code	Ref country code: DE Ref legal event code: R097 Ref document number: 602018064676 Country of ref document: DE
2024-10-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-11-20	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-11-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240124
2024-11-29	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2024-11-29	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2024-11-29	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2025-01-01	26N	No opposition filed	Effective date: 20241025
2025-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240430
2025-04-22	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240427
2025-05-28	U20	Renewal fee for the european patent with unitary effect paid	Year of fee payment: 8 Effective date: 20250424
2025-07-10	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: GB Payment date: 20250423 Year of fee payment: 8
2025-08-07	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20180427
2025-09-03	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20180427

Publication	Publication Date	Title
EP4365597C0 (de)	2025-07-23	Verfahren zur untersuchung von proteinen
EP3541279C0 (de)	2023-09-06	Vorrichtungen zur verbesserung der peripheren nervenfunktion
EP3263132C0 (de)	2023-12-06	Zusammensetzung zur behandlung von il-6-assoziierten erkrankungen
EP3538078A4 (de)	2020-07-08	Formulierungen zur effizienten verabreichung von cannabinoiden
EP3649250A4 (de)	2021-03-24	Assay zur präoperativen vorhersage der wiederherstellung der organfunktion
EP3518902A4 (de)	2020-07-08	Magenverweilsysteme zur retard-freisetzung von wirkstoffen
EP3377068C0 (de)	2025-03-26	Kombinationstherapie von tetracyclischen chinolonanalogen zur behandlung von krebs
IL262211A (en)	2018-11-29	Gene therapy for treating mucopolysaccharidosis type ii
EP3768240A4 (de)	2021-12-22	Ionische flüssige zusammensetzungen zur behandlung von rosacea
EP3531835C0 (de)	2026-01-07	Materialien und verfahren zur bekämpfung von nematoden
EP3324965A4 (de)	2019-07-03	Gamma-sekretase-modulatoren zur behandlung von immunsystemstörungen
LT3636649T (lt)	2024-04-10	Diarilo makrociklai kaip proteinkinazių moduliatoriai
EP3750530C0 (de)	2025-12-24	Kombinationen von irs/stat3-doppelmodulatoren und antikrebsmittel zur behandlung von krebs
EP4094723C0 (de)	2024-10-23	Vorrichtungen zur implantation medizinischer vorrichtungen
EP3266380C0 (de)	2024-12-25	Ermittlung von gewebedicke
EP3640320A4 (de)	2021-03-17	Kryokonservierungsvorrichtung zur kryokonservierung von zellen oder gewebe
IL256103B (en)	2022-01-01	Compositions and methods for treating celiac sprue disease
EP3341398C0 (de)	2024-12-18	Verbindungen zur induzierung von gewebebildung und verwendungen davon
IL251349A0 (en)	2017-05-29	Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
EP3465427A4 (de)	2020-01-15	Choreografierte verteilte ausführung von programmen
EP3983360C0 (de)	2025-11-05	Zersetzung von struvit
EP3561511A4 (de)	2020-07-01	Streifen zur messung von blutfetten
EP3337777C0 (de)	2025-01-01	Verfahren zur herstellung von c3-chlorierten alkan- und alkenverbindungen
EP3562937A4 (de)	2020-09-16	Gentherapie zur behandlung von mukopolysaccharidose typ ii
EP3498149A4 (de)	2020-07-22	Optoelektronisches binokulares instrument zur korrektur von altersweitsichtigkeit und verfahren zur binokularen korrektur von altersweitsichtigkeit